CSII News Alert Cardiovascular Systems (CSII) 35.69 02/14/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cardiovascular Systems (CSII) 35.69 $CSII

Medtronic's Reveal Cardiac Monitor: Key to AF Detection - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 2:15PM CST
The incremental cost-effectiveness ratio (ICER) associated with the utilization of Medtronic's (MDT) Reveal XT ICM came well within the cost-effectiveness range supported by the United Kingdom's National Institute of Clinical Excellence.
CSII: 35.69 (+0.17), MDT: 75.26 (+0.33), PAHC: 30.85 (+0.36), ABAX: 60.93 (+0.65)

Uptrend Call Working As Cardiovascular Systems Stock Rises 31.5% (CSII)
Comtex SmarTrend(R) - Fri Feb 13, 10:58AM CST
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on October 17th, 2014 at $27.13. In approximately 4 months, Cardiovascular Systems has returned 31.51% as of today's recent price of $35.68.
CSII: 35.69 (+0.17)

St. Jude Medical HALO US IDE Trial Tests 15mm Heart Valves - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 3:13PM CST
Global medical devices company, St. Jude Medical (STJ), recently launched the HALO U.S. IDE Trial.
CSII: 35.69 (+0.17), PAHC: 30.85 (+0.36), ABAX: 60.93 (+0.65), STJ: 67.48 (+0.65)

ResMed Targets Expansion in HME Market, Acquires Jaysec - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 3:09PM CST
Through Jaysec's acquisition, ResMed (RMD) will experience reduced administrative burden owing to the self-serve software portal specifically designed for HME providers.
CSII: 35.69 (+0.17), PAHC: 30.85 (+0.36), ABAX: 60.93 (+0.65), RMD: 66.25 (+0.79)

Cardiovascular Systems Has Returned 29.3% Since SmarTrend Recommendation (CSII)
Comtex SmarTrend(R) - Fri Feb 06, 9:34AM CST
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on October 17th, 2014 at $27.13. In approximately 4 months, Cardiovascular Systems has returned 29.27% as of today's recent price of $35.07.
CSII: 35.69 (+0.17)

Update: Cardiovascular Systems Posted Impressive Fiscal 2015 Q2 Earnings
Andy Batts - at Seeking Alpha - Fri Feb 06, 8:04AM CST

CSII: 35.69 (+0.17)

Insider Trading Alert - SCTY, FBIZ And CSII Traded By Insiders
at The Street - Wed Feb 04, 11:13AM CST
Stocks with insider trader activity include SCTY, FBIZ and CSII
CSII: 35.69 (+0.17), SCTY: 57.60 (+0.44), FBIZ: 46.60 (+0.47)

Boston Scientific Tops Q4 Earnings, Revenues Miss Mark - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 04, 9:27AM CST
Boston Scientific (BSX) reported adjusted earnings per share (EPS) (after considering certain one-time adjustments other than amortization expense) of 22 cents in the fourth quarter of 2014.
BSX: 14.98 (+0.24), ICUI: 88.98 (+0.42), CSII: 35.69 (+0.17), ABAX: 60.93 (+0.65)

Haemonetics Q3 Earnings Top Estimates, Drop Y/Y; Stock Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 02, 9:00AM CST
Although Haemonetics' (HAE) earnings topped the Zacks Consensus Estimate, it reflected a significant slash year-over-year. With the bleak performance of blood center as well as hospital disposable businesses, the top line too failed to meet our expectation
ICUI: 88.98 (+0.42), CSII: 35.69 (+0.17), ABAX: 60.93 (+0.65), HAE: 42.94 (-0.59)

Zacks Rank #1 Additions for Monday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 02, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday
ABMD: 60.39 (+0.46), CSII: 35.69 (+0.17), CACB: 4.90 (+0.12), CSIQ: 28.84 (-0.30), CBF: 26.04 (-0.09)

Can the Rally in Cardiovascular Systems (CSII) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 02, 6:59AM CST
Can the Rally in Cardiovascular Systems (CSII) Shares Continue?
CSII: 35.69 (+0.17)

29.0% Return Seen to Date on SmarTrend Cardiovascular Systems Call (CSII)
Comtex SmarTrend(R) - Fri Jan 30, 9:09AM CST
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on October 17th, 2014 at $27.13. In approximately 4 months, Cardiovascular Systems has returned 28.97% as of today's recent price of $34.99.
CSII: 35.69 (+0.17)

Nasdaq stocks posting largest percentage increases
AP - Thu Jan 29, 5:14PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
NVEE: 12.60 (+0.05), INTG: 19.80 (+0.51), RESN: 16.62 (-1.38), ABMD: 60.39 (+0.46), ACAT: 39.00 (+1.31), CSII: 35.69 (+0.17), EA: 56.39 (+0.20), AFMD: 5.70 (-0.25), ADVS: 44.18 (+0.20), NVC.TO: 11.27 (-0.23), NVCN: 9.08 (-0.17), OMER: 20.63 (+0.13)

Zimmer (ZMH) Q4 Earnings Beat, Revenues Miss Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 29, 10:13AM CST
Zimmer Holdings (ZMH) reported fourth-quarter 2014 adjusted earnings per share (EPS) of $1.71, up 3% year over year.
MGNX: 34.09 (+0.10), ZMH: 119.33 (+1.18), CSII: 35.69 (+0.17), OSUR: 8.13 (+0.06)

Cardiovascular Systems (CSII) Is Strong On High Volume Today
at The Street - Thu Jan 29, 9:07AM CST
Trade-Ideas LLC identified Cardiovascular Systems (CSII) as a strong on high relative volume candidate
CSII: 35.69 (+0.17)

Cardiovascular Systems' (CSII) CEO Dave Martin on Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Jan 28, 9:45PM CST

CSII: 35.69 (+0.17)

Cardiovascular Systems reports 2Q loss
Automated Insights - Wed Jan 28, 3:48PM CST
ST. PAUL, Minn. (AP) _ Cardiovascular Systems Inc. (CSII) on Wednesday reported a loss of $5.3 million in its fiscal second quarter.
CSII: 35.69 (+0.17)

Cardiovascular Systems (CSII) Q2 2015 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Jan 28, 3:40PM CST

CSII: 35.69 (+0.17)

Cardiovascular Systems beats by $0.18, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Jan 28, 3:14PM CST

CSII: 35.69 (+0.17)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Arkestro Recognized as Leading Sourcing Tech Solution in 2024

Updated Category News Views 138

Arkestro Celebrated as a Leading Sourcing Technology Provider Arkestro's innovative Predictive Procurement Orchestration AI platform has been recognized among the top contenders in the industry. This recognition comes as part of Spend Matters' release of their Fall 2024 SolutionMap, which acknowledges the leading procurement technology vendors. Out of 93 companies...

Continue Reading
Nanoscope Therapeutics Welcomes Ademola Daramola as VP of Quality

Updated Category News Views 178

Nanoscope Therapeutics Expands Leadership Team Nanoscope Therapeutics Inc., a dedicated biotechnology firm, strives to restore vision for blind patients through pioneering gene therapies. The company has recently appointed Ademola Daramola, D.Sc., as the Vice President of Quality and Compliance. Introducing Dr. Ademola Daramola Dr. Daramola joins Nanoscope with an...

Continue Reading
Lumentum Holdings Readies for Earnings Report with Optimism

Updated Category News Views 220

Lumentum Holdings Prepares for Earnings Release Lumentum Holdings (NASDAQ: LITE) is set to announce its quarterly earnings soon. Investors are eager to see what insights will emerge from the report, as expectations build around the company's performance. Investor Expectations and Earnings Forecast Analysts predict that Lumentum Holdings will post an earnings per share...

Continue Reading
LightPath Technologies Launches Infrared Solutions for Defense

Updated Category News Views 130

LightPath Technologies Initiates Delivery of Infrared Assemblies FPV Drone Infrared Lens Assemblies for European Defense Customer Expected to Drive $1.0-2.0 Million in Revenue in Calendar Year 2025 LightPath Technologies, Inc. (NASDAQ: LPTH), renowned for its advanced optics and imaging systems targeted at both defense and commercial utilizations, has announced that it...

Continue Reading
The RealReal Boosts Revenue and Adjusted EBITDA in Q3 2024

Updated Category News Views 57

Strong Q3 2024 Performance for The RealReal The RealReal (NASDAQ: REAL), a leader in the online marketplace for authenticated, resale luxury goods, reported significant financial gains in the third quarter of 2024. The company achieved a revenue of $148 million, which represents an increase of $15 million or 11% compared to the previous year. Notably, they also saw...

Continue Reading